Table 1 MCL patient information Patient... | American Society of Hematology

Table 1

MCL patient information

Patient no.	Age, y	Sex	Type	Stage	LDH, U/L	WBCs, ×10³/μL	Ki67, percentage	Bcl-1, percentage	ECOG	IPI	MIPI	OS until last follow-up
1	54	Male	Classic	2	749	17.1	< 10	90	1	2	6	8 y
2	75	Male	Classic	4	560	25.4	30	ND	4	4	10	4 y
3	81	Male	Blastic	4	1080	6.08	64	77	2	4	9	1 y*
4	58	Male	Classic	4	342	157	10-15	80-90	4	3	7	2 y*
5	45	Male	Classic	4	520	5.54	8	85 var	1	1	1	5 y
6	56	Male	Classic	4	309	6.84	10-15	100 weak	0	2	2	7 y
7	60	Male	Classic	4	1561	252	10	52	2	5	11	3 mo*
8	64	Male	Classic	4	1386	5.47	38	30	2	4	8	6 y*
9	66	Male	Blastic	4	536	5.18	38	85	3	4	6	4 y*
10	62	Male	Classic	4	541	7.03	40	Positive	4	4	7	3.5 y*
11	65	Male	Classic	4	548	18	40	Positive	2	4	9	5 y*
12	76	Male	Classic	4	317	11.9	9	70 var	2	4	8	2 y*
13	58	Male	Blastic	4	1852	157	ND	ND	4	5	11	2 y*
14	76	Male	Classic	3	780	5.52	20	90	0	3	5	3 y
15	65	Male	Classic	2	416	7.39	ND	88 var	2	2	7	1.5 y*
16	57	Male	Classic	4	331	4.42	30	90	1	2	1	1.5 y*
17	65	Male	Classic	4	338	7.65	30	90	1	3	3	4 y
18	70	Male	Classic	4	620	5.78	40-50	90	1	3	5	3 y
19	80	Male	Classic	2	472	22.2	95	85	4	2	10	3 mo*
20	66	Female	Classic	4	623	4.43	22	95	0	4	4	3 y
21	81	Male	Classic	4	436	4.1	20-30	30	2	4	7	2.5 y
22	81	Female	Classic	4	325	8.1	63	87 var	3	3	7	1 y
23	61	Male	Classic	4B	624	2.6	57	95 weak	0	4	3	4 y
24	70	Male	Classic	4	699	6.45	10	Positive	0	3	5	5 mo*
25	65	Male	Classic	4	415	6.99	5-10	78 weak	2	4	7	2 y
26	65	Male	Classic	4	588	4.43	30	> 95	2	3	6	3.5 y
27	62	Female	Classic	3	528	4.6	25	80	0	2	3	2 y
28	45	Male	Classic	4	441	5.54	10	85 var	1	1	2	5 y
29	62	Male	Classic	4	ND	5.39	30-40	90	1	2	2	2 mo
30	52	Female	Classic	4	540	8.5	9	42	1	2	3	1.4 y

Patient no.	Age, y	Sex	Type	Stage	LDH, U/L	WBCs, ×10³/μL	Ki67, percentage	Bcl-1, percentage	ECOG	IPI	MIPI	OS until last follow-up
1	54	Male	Classic	2	749	17.1	< 10	90	1	2	6	8 y
2	75	Male	Classic	4	560	25.4	30	ND	4	4	10	4 y
3	81	Male	Blastic	4	1080	6.08	64	77	2	4	9	1 y*
4	58	Male	Classic	4	342	157	10-15	80-90	4	3	7	2 y*
5	45	Male	Classic	4	520	5.54	8	85 var	1	1	1	5 y
6	56	Male	Classic	4	309	6.84	10-15	100 weak	0	2	2	7 y
7	60	Male	Classic	4	1561	252	10	52	2	5	11	3 mo*
8	64	Male	Classic	4	1386	5.47	38	30	2	4	8	6 y*
9	66	Male	Blastic	4	536	5.18	38	85	3	4	6	4 y*
10	62	Male	Classic	4	541	7.03	40	Positive	4	4	7	3.5 y*
11	65	Male	Classic	4	548	18	40	Positive	2	4	9	5 y*
12	76	Male	Classic	4	317	11.9	9	70 var	2	4	8	2 y*
13	58	Male	Blastic	4	1852	157	ND	ND	4	5	11	2 y*
14	76	Male	Classic	3	780	5.52	20	90	0	3	5	3 y
15	65	Male	Classic	2	416	7.39	ND	88 var	2	2	7	1.5 y*
16	57	Male	Classic	4	331	4.42	30	90	1	2	1	1.5 y*
17	65	Male	Classic	4	338	7.65	30	90	1	3	3	4 y
18	70	Male	Classic	4	620	5.78	40-50	90	1	3	5	3 y
19	80	Male	Classic	2	472	22.2	95	85	4	2	10	3 mo*
20	66	Female	Classic	4	623	4.43	22	95	0	4	4	3 y
21	81	Male	Classic	4	436	4.1	20-30	30	2	4	7	2.5 y
22	81	Female	Classic	4	325	8.1	63	87 var	3	3	7	1 y
23	61	Male	Classic	4B	624	2.6	57	95 weak	0	4	3	4 y
24	70	Male	Classic	4	699	6.45	10	Positive	0	3	5	5 mo*
25	65	Male	Classic	4	415	6.99	5-10	78 weak	2	4	7	2 y
26	65	Male	Classic	4	588	4.43	30	> 95	2	3	6	3.5 y
27	62	Female	Classic	3	528	4.6	25	80	0	2	3	2 y
28	45	Male	Classic	4	441	5.54	10	85 var	1	1	2	5 y
29	62	Male	Classic	4	ND	5.39	30-40	90	1	2	2	2 mo
30	52	Female	Classic	4	540	8.5	9	42	1	2	3	1.4 y

ECOG indicates Eastern Cooperative Oncology Group; LDH, lactate dehydrogenase; WBCs, white blood cells; ND, not done; and var, variable.

Death.